Early PD-1 Therapy Discontinuation in Responding Metastatic Cancer Patients

Conclusion: The results of the current study suggest that patients whose PD-1 therapy has been discontinued in response can have a long IO therapy-free period without need for a next line of therapy.Oncology
Source: Oncology - Category: Cancer & Oncology Source Type: research